Navigation Links
DS Chemphy Focusing on CRO/CMO Business
Date:2/9/2010

WILMINGTON, Del., Feb. 9 /PRNewswire/ -- The rapid increase of cost in China has brought some shadow to the CRO and CMO businesses there. However, DS Chemphy, Inc., a USA-based contract research and manufacturing organization that focuses on fine and pharmaceutical chemicals, continues investing in its businesses. "Our competitive advantages are not only low costs," said Dr. Aaron Shen, CEO of the company.

Dr. Shen continues: "What makes Chemphy so attractive to our customers? The answers are: high-standard EHS management, high quality products and services, proprietary technologies, high efficiency, excellent IP protection, active communication, and integrated capability from R&D to manufacture."

Since DS Chemphy acquired New Chemphy in 2007, DS Chemphy has invested over $45 million in CRO/CMO capability as well as corporate culture and management reform. New Chemphy was founded by the Chinese Academy of Sciences. DS Chemphy integrated Chinese and Western advantages, i.e. lower costs of China and high-standard quality management of the West. The successful story was reported by C&E News (Issue Sept 1, 2008, page 35).

Most senior executives of the company have overseas training or work experience. The company now employs over 1000 chemical professionals. Last year, the company built a world-class R&D center. 150 chemists, including 25 PhDs, work in the center. The labs are equipped with state-of-the-art instruments including NMR, LC-MS, GC-MS, DSC, RC1, and GPC. The company has two manufacturing sites capable of production at pilot, multi-functional, and commercial scale. The reactors cover all sizes up to 20M(3). The reactors are either made of stainless steel, or glass-lined, nickel-lined, titanium-lined, Hastelloy-lined or polytetrafluoroethylene-lined.

DS Chemphy offers quality products based on Chemphy proprietary technology platforms including cyclopropanation, fluorination, and catalytic continues process, etc.

Recently DS Chemphy launched three new products:

Cyclopentyl methyl ether -- THF alternative

ChemphySteel® -- Polymers as strong as steel

ChemphyFresh® -- Keep your fruits and vegetables fresh

Visit us at booth 117 at InformEx USA, San Francisco, CA February 16-19, 2010, or www.dschemphy.com. You may also contact Aaron Shen, President of DS Chemphy at tel: 302-351-8401, fax: 302-351-6101 or email: ashen@dschemphy.com.

SOURCE DS Chemphy, Inc.

RELATED LINKS
http://www.dschemphy.com

'/>"/>

SOURCE DS Chemphy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
2. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
5. Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company
6. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
7. Los Angeles Business Owner Pleads Guilty to Submitting Nearly $1 Million in False and Fraudulent Claims to Medicare
8. Highlights of Economic and Business Growth in the Tampa Bay Region
9. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
10. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
11. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):